Pharma News

FDA Releases Draft Guidance on Confirmatory Trials for Accelerated Approvals

Resolute's RZ358 gains FDA recognition for groundbreaking treatment of hyperinsulinemia-related hypoglycemia

FDA Grants Fast Track Designation to Posdinemab for Early Alzheimer Disease

MAIA Biotechnology Announces Clinical Supply Agreement with BeiGene for Upcoming Phase 2 Trials in Three Cancer Indications

Quris-AI's Bio-AI Platform Integrated by Merck KGaA, Darmstadt, Germany for Preclinical Small Molecule Drug Safety Evaluation

The U.S. continues to charge significantly higher prices for prescription drugs compared with similarly wealthy countries.  The start of the new year is typically a time when people make big...

A twice-yearly injection reduces the risk of HIV infection by 96%. That’s according to a clinical trial led by physicians at Emory University and the Grady Health System.

China National Medical Products Administration (NMPA) has granted acceptance and priority review for the new drug application (NDA) for HUTCHMED’s ORPATHYS (savolitinib) and ...

Testing Services Market Outlook, 2025-2035 - Dominated by Charles River Laboratories Int'l, Eurofins Scientific, SGS, WuXi AppTec, and Pace Analytical Services

The Indian Institute of Technology (IIT) Guwahati and the Bose Institute Kolkata research team have developed an advanced injectable hydrogel designed to release anti-cancer therapies to tumou...

The approval marks the second for a generic in this class of medications indicated to improve glycemic control in patients with type 2 diabetes as a complement to diet and exercise.

The Texas-based company has said it will investigate the results of its rheumatoid arthritis trial after finding irregularities.  XBiotech’s stock price has taken a hit after it announced ...